Azelastine [clinicaltrials_resource:8392c23440ff4ab479a3273f1fd10de1]
clinicaltrials:NCT00561717A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis [clinicaltrials:NCT00612118]clinicaltrials:NCT00651118clinicaltrials:NCT00660517clinicaltrials:NCT00660829clinicaltrials:NCT00712920clinicaltrials:NCT00719862clinicaltrials:NCT00720278clinicaltrials:NCT00720382clinicaltrials:NCT00740792clinicaltrials:NCT00772304clinicaltrials:NCT00783432Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) [clinicaltrials:NCT00806754]clinicaltrials:NCT00824473Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid [clinicaltrials:NCT00845195]clinicaltrials:NCT00845598clinicaltrials:NCT00883168Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis [clinicaltrials:NCT00940953]clinicaltrials:NCT00979615clinicaltrials:NCT01018862Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays [clinicaltrials:NCT01190852]Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays [clinicaltrials:NCT01194622]A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies [clinicaltrials:NCT01368445]Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis [clinicaltrials:NCT01382654]Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis [clinicaltrials:NCT01470053]clinicaltrials:NCT01880840clinicaltrials:NCT01915823Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis [clinicaltrials:NCT02230696]AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) [clinicaltrials:NCT02238353]Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™ [clinicaltrials:NCT02249663]A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis [clinicaltrials:NCT02279563]clinicaltrials:NCT02402465
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Azelastine [clinicaltrials_resource:8392c23440ff4ab479a3273f1fd10de1]
Bio2RDF identifier
8392c23440ff4ab479a3273f1fd10de1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8392c23440ff4ab479a3273f1fd10de1
identifier
clinicaltrials_resource:8392c23440ff4ab479a3273f1fd10de1
title
Azelastine
@en
type
label
Azelastine [clinicaltrials_resource:8392c23440ff4ab479a3273f1fd10de1]
@en